| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 797 | 672 | +18.5% |
| EBITDA | 39.0 | 30.4 | +28.4% |
| EBITDA margin | 4.9% | 4.5% | +0.4 pts |
| Profit before tax | 27.8 | 21.9 | +26.6% |
| Net profit | 20.6 | 16.4 | +26.1% |
| EPS | ₹6.69 | ₹5.38 | +24.3% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 653 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 11.9 | 11.9 | 7.7 | 10.4 | 12.1 | ||
| 31.7 | 31.7 | 32.6 | 33.4 | 30.9 | ||
| 127 | 127 | 106 | 153 | 83.8 | ||
| 800 | — | — | — | — | ||
| 2,530 | 2,406 | 2,528 | 2,150 | 2,772 | ||
| — | −4.8% | +17.6% | −22.4% | — | ||
| 112 | 104 | 109 | 97.3 | 97.2 | ||
| 4.4% | 4.3% | 4.3% | 4.5% | 3.5% | ||
| 90.3 | 82.1 | 89.4 | 81.4 | 81.8 | ||
| 54.4 | 50.2 | 53.8 | 55.5 | 51.9 | ||
| 2.2% | 2.1% | 2.1% | 2.6% | 1.9% | ||
| ₹18.11 | ₹16.80 | ₹18.30 | ₹17.59 | ₹16.45 | ||
| — | −8.2% | +4.1% | +6.9% | — | ||
| — | 43.5 | 118 | 16.9 | 123 | ||
| — | −34.2 | −28.2 | −53.3 | −40.9 | ||
| 9.4 | 9.4 | 89.8 | −36.4 | 81.6 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 653.2 | |
| - Cash, Equiv & ST Investments | 12.1 | 10.4 | 7.7 | 11.9 | 11.9 | |
| + Minority Interest | 30.9 | 33.4 | 32.6 | 31.7 | 31.7 | |
| + Total Debt | 83.8 | 153.2 | 105.9 | 126.6 | 126.6 | |
| Enterprise Value | — | — | — | — | 799.6 | |
| Revenue | 2,771.6 | 2,150.0 | 2,528.2 | 2,405.7 | 2,530.2 | |
| Growth %, YoY | — | -22.4 | +17.6 | -4.8 | — | |
| EBITDA | 97.2 | 97.3 | 108.8 | 103.8 | 112.4 | |
| Margin % | 3.51 | 4.53 | 4.30 | 4.32 | 4.44 | |
| EBIT | 81.8 | 81.4 | 89.4 | 82.1 | 90.3 | |
| Net Income | 51.9 | 55.5 | 53.8 | 50.2 | 54.4 | |
| Margin % | 1.87 | 2.58 | 2.13 | 2.09 | 2.15 | |
| EPS, Adj (current shares) | 16.45 | 17.59 | 18.30 | 16.80 | 18.11 | |
| Growth %, YoY | — | +6.9 | +4.1 | -8.2 | — | |
| Cash from Operations | 122.5 | 16.9 | 118.0 | 43.5 | — | |
| Capital Expenditures | -40.9 | -53.3 | -28.2 | -34.2 | — | |
| Free Cash Flow | 81.6 | -36.4 | 89.8 | 9.4 | 9.4 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Jayant Agro Organics (NSE: JAYAGROGN) had a market capitalisation of ₹635 crore at the 30 October 2026 close (₹211.53 a share), a PE ratio of 11.7 on the last four quarters' profit and a price-to-book ratio of 1.04. In FY26 its consolidated net profit attributable to shareholders was ₹50.4 crore on revenue of ₹2,406 crore; in Q1 FY27 (April–June 2026) it was ₹20.1 crore, up 24.2% year on year. Its debt-to-equity ratio was 0.20 on 31 March 2026. Promoters held 67.21% of the shares on 30 September 2026.
Jayant Agro Organics' PE ratio is 11.7 at the 30 October 2026 close (₹211.53 a share): a market capitalisation of ₹635 crore divided by consolidated net profit attributable to shareholders of ₹54.3 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹50.4 crore) it is 12.6.
Jayant Agro Organics' price-to-book (PB) ratio is 1.04 at the 30 October 2026 close: a market capitalisation of ₹635 crore divided by shareholders' equity (book value) of ₹610 crore on 31 March 2026. That is a book value of ₹203.36 per share against a share price of ₹211.53.
In FY26, Jayant Agro Organics' return on equity (ROE) was 8.5% and its return on capital employed (ROCE) was 12.3%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 9.8% and ROCE 14.0%.
Jayant Agro Organics' market capitalisation was ₹635 crore at the 30 October 2026 close: 3 crore shares at ₹211.53 each.
No. Jayant Agro Organics had borrowings of ₹127 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.20. Its cash and current investments were ₹12.5 crore, so its net debt was ₹114 crore.
In 2026, Jayant Agro Organics has declared one dividend: ₹3.50 with record date 7 August 2026.
Jayant Agro Organics' debt-to-equity ratio was 0.20 on 31 March 2026: borrowings of ₹127 crore against total equity of ₹642 crore. A year earlier, on 31 March 2025, it was 0.17.
Jayant Agro Organics' net worth — shareholders' equity in its consolidated balance sheet — was ₹610 crore on 31 March 2026, up 5.8% from ₹577 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹635 crore at the 30 October 2026 close.
Jayant Agro Organics' book value per share was ₹203.36 on 31 March 2026: shareholders' equity of ₹610 crore divided by the 3 crore shares in issue, up 5.8% from ₹192.29 a year earlier. The share price at the 30 October 2026 close was ₹211.53.
Jayant Agro Organics' basic earnings per share (EPS) were ₹16.80 in FY26, against ₹18.30 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹18.11.
Jayant Agro Organics' dividend yield is 1.65% at the 30 October 2026 close: dividends of ₹3.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹211.53. They were ₹3.50 on 7 August 2026.
Jayant Agro Organics will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, the date of the board meeting it has notified to the exchanges.
Promoters held 67.21% of Jayant Agro Organics on 30 September 2026, up 0.08 percentage points from 67.13% the previous quarter and up 0.09 percentage points from 67.12% a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Jayant Agro Organics generated ₹43.5 crore of cash from operations and spent ₹34.2 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹9.4 crore. In FY25 it was ₹89.8 crore.
Jayant Agro Organics' latest results are for Q1 FY27 (April–June 2026), filed on 31 July 2026: consolidated net profit attributable to shareholders ₹20.1 crore, up 24.2% from ₹16.1 crore in Q1 FY26; revenue from operations ₹797 crore, up 18.5% year on year.
On 30 September 2026, Jayant Agro Organics' shares were held by promoters 67.21%, foreign portfolio investors (FII/FPI) 0.07%, domestic institutions (DII) 0.02% and retail and other non-institutional investors 32.71%. Over the year, FII holding was up 0.03 percentage points from 0.04%.
In FY26 (April 2025–March 2026), Jayant Agro Organics' consolidated net profit attributable to shareholders was ₹50.4 crore, down 8.2% from ₹54.9 crore in FY25, on revenue from operations of ₹2,406 crore (down 4.8%). Over three years, from FY23, net profit was up 2.2%.
At the 30 October 2026 closing prices, on FY26 net profit attributable to shareholders, Jayant Agro Organics' PE ratio is 12.6, the third highest of the four: Kronox Lab Sciences 25.0, DMCC SPECIALITY CHEMICALS 23.2 and Sree Rayalaseema Hi-Strength Hypo 9.2, a peer average of 19.1. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On FY26 consolidated figures, against Kronox Lab Sciences, DMCC SPECIALITY CHEMICALS and Sree Rayalaseema Hi-Strength Hypo: Jayant Agro Organics' operating margin of 3.4% is the lowest of the four (Kronox Lab Sciences 31.8%, DMCC SPECIALITY CHEMICALS 8.2%, Sree Rayalaseema Hi-Strength Hypo 12.2%; peer average 17.4%); its return on equity of 8.5% is the lowest of the four (Kronox Lab Sciences 26.8%, DMCC SPECIALITY CHEMICALS 11.5%, Sree Rayalaseema Hi-Strength Hypo 9.5%; peer average 16.0%).
In FY26, Jayant Agro Organics earned net profit attributable to shareholders of ₹50.4 crore on revenue of ₹2,406 crore, against ₹27.7 crore on ₹101 crore for Kronox Lab Sciences. Jayant Agro Organics' operating margin was 3.4% (Kronox Lab Sciences 31.8%) and its return on equity 8.5% (Kronox Lab Sciences 26.8%). At the 30 October 2026 close, Jayant Agro Organics' market capitalisation was ₹635 crore against ₹691 crore for Kronox Lab Sciences, and its PE ratio on FY26 profit 12.6 against 25.0.
From Jayant Agro Organics' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.